Publications by authors named "Vivekka Nagendran"
Article Synopsis
- Dermatochalasis can obstruct vision and hinder daily activities, and blepharoplasty is a surgical option that may be viewed as cosmetic by insurance providers.
- A study analyzed 70 insurance policies on blepharoplasty, revealing that 96% provide coverage, mainly for conditions like functional visual impairment due to dermatochalasis.
- However, there are inconsistencies in insurance criteria, particularly regarding visual field loss requirements, with many companies demanding stricter standards than recommended by existing literature.
Purpose: To examine a large cohort of patients treated with biologic agents for active noninfectious intermediate uveitis, posterior uveitis, or panuveitis (NIPPU) and to compare their efficacy and long-term effect.
Design: Retrospective, longitudinal study.
Participants: Eighty-two patients (156 eyes) with active NIPPU after failure of treatment with corticosteroids and a second-line immunosuppression drug and treated with biologic agents who were treated at Moorfields Eye Hospital between 2001 and 2016.